Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Biomarin Pharmaceutical is 43 — signals are mixed heading into the print. Underlying trend: 5 tracked signals showing mixed direction over the last 3 months.
Biomarin Pharmaceutical (BMRN) is trading at $69.55, up 29.9% over the last 3 months (from $53.55 three months ago).
Trends across the last 3 months — the run-up to Biomarin Pharmaceutical’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 229 | ↓ -11.2% |
| LinkedIn headcount | 3,218 | → +1.6% |
| Web traffic | 103,976 | → +0.5% |
| Employee business outlook | 27% Negative | ↑ +3pp |
| Instagram followers | 4,219 | → +0.0% |
Full daily-resolution trend charts on every signal are on the BMRN ticker page.
AltIndex stock alerts fire when alt-data on BMRN breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Biomarin Pharmaceutical — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in